Combating antibiotic resistance: mechanisms, challenges, and innovative approaches in antibacterial drug development
Aiswarya Rajesh,
No information about this author
Sunita Pawar,
No information about this author
Kruthi Doriya
No information about this author
et al.
Published: Jan. 26, 2025
Antibiotic
resistance
is
a
significant
threat
to
public
health
and
drug
development,
driven
largely
by
the
overuse
misuse
of
antibiotics
in
medical
agricultural
settings.
As
bacteria
adapt
evade
current
drugs,
managing
bacterial
infections
has
become
increasingly
challenging,
leading
prolonged
illnesses,
higher
healthcare
costs,
increased
mortality.
This
review
explores
critical
role
fighting
mechanisms
that
enable
resist
them.
Key
discussed
include
carvacrol,
dalbavancin,
quinolones,
fluoroquinolones,
zoliflodacin,
each
with
unique
actions
against
pathogens.
Bacteria
have
evolved
complex
strategies,
such
as
enzyme
production
neutralize
modifying
targets,
using
efflux
pumps
remove
antibiotics,
significantly
reducing
efficacy.
Additionally,
examines
challenges
antibiotic
including
declining
discovery
rate
novel
drugs
due
high
costs
regulatory
complexities.
Innovative
approaches,
structure-based
design,
combination
therapies,
new
delivery
systems,
are
highlighted
for
their
potential
create
compounds
enhanced
action
resistant
strains.
provides
valuable
insights
researchers
developers
aiming
combat
advance
development
robust
antibacterial
therapies
future
security.
Language: Английский
From Canonical to Unique: Extension of A Lipophilicity Scale of Amino Acids to Non-Standard Residues
Published: Jan. 31, 2024
The
lipophilicity
of
amino
acids
plays
a
pivotal
role
in
determining
their
physicochemical
properties
as
it
gives
an
estimate
solubility,
binding
propensity,
and
bioavailability.
Herein,
we
applied
the
IEFPCM/MST
implicit
solvation
model
to
compute
n-octanol/water
partition
coefficient
lipophilic
descriptor
for
non-standard
acids.
Thus,
extending
our
previous
work
on
hydrophobicity
scale
To
this
end,
employed
two
structural
models,
named
Model
1
2,
differentiated
solely
by
C-terminal
capping
groups
using
N-
or
O-
methyl
substituent,
respectively.
Our
findings
revealed
substantial
similarities
between
validating
values
side
chains.
Differences
were
observed
fewer
cases,
indicating
effect
group
chain
hydrophobicity.
This
is
expected
one
contains
hydrogen
bond
donor
(Model
1)
while
other
uses
acceptor
2).
Overall,
both
models
exhibit
strong
correlations
with
experimental
values,
showing
lower
statistical
errors.
In
addition,
predictions
able
correctly
predict
change
due
number
acetylated
lysines
peptide
pairs
determined
HPLC,
suggesting
that
can
be
proteomics
studies
include
post-translational
modifications
beyond
acetylation.
Language: Английский